Onion bulb formation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Axonal regeneration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Slow progression
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Charcot-Marie-Tooth Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Exome sequencing identified a novel heterozygous nonsynonymous variant (NM_021629.3:c.659T > C [p.Gln220Arg]) in GNB4 exon 8, which is known to be responsible for CMT.
|
28642160 |
2017 |
Charcot-Marie-Tooth Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Here we present a patient with CMT in whom whole exome sequencing identified the mutation p.Lys57Glu in the GNB4 gene (NM_021629.3:c.169A>G).
|
27908631 |
2017 |
Charcot-Marie-Tooth Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
This study identifies GNB4 mutations as a cause of CMT and highlights the importance of Gβ4-related GPCR signaling in peripheral-nerve function in humans.
|
23434117 |
2013 |
Malignant neoplasm of urinary bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
As previously shown, intron 1 of GNB4 harbours distinct haplotype blocks and block 1 is associated with survival and disease progression in urothelial bladder cancer.
|
19414374 |
2009 |
Bladder Neoplasm
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
As previously shown, intron 1 of GNB4 harbours distinct haplotype blocks and block 1 is associated with survival and disease progression in urothelial bladder cancer.
|
19414374 |
2009 |
Carcinoma of bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
As previously shown, intron 1 of GNB4 harbours distinct haplotype blocks and block 1 is associated with survival and disease progression in urothelial bladder cancer.
|
19414374 |
2009 |
Malignant neoplasm of urinary bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer.
|
18815590 |
2008 |
Bladder Neoplasm
|
0.020 |
GeneticVariation
|
disease |
LHGDN |
Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer.
|
18815590 |
2008 |
Bladder Neoplasm
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer.
|
18815590 |
2008 |
Carcinoma of bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
|
18815590 |
2008 |
Ulcerative Colitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Of note, the hub genes G protein subunit gamma 11 (GNG11), G protein subunit beta 4 (GNB4), Angiotensinogen (AGT), Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) and C-C motif chemokine receptor 7 (CCR7) are disease-specific and may be used as biomarkers for differentiating UC from CD.
|
31258663 |
2019 |
Crohn Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Of note, the hub genes G protein subunit gamma 11 (GNG11), G protein subunit beta 4 (GNB4), Angiotensinogen (AGT), Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) and C-C motif chemokine receptor 7 (CCR7) are disease-specific and may be used as biomarkers for differentiating UC from CD.
|
31258663 |
2019 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 might be predictive markers for survival of patients with advanced colorectal cancer, thus influencing the clinical management of these patients.
|
19414374 |
2009 |
Tumor Progression
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
As G beta gamma signaling is presumed to be involved in proliferation and invasion processes, we analyzed genetic variations in regulatory regions of GNB4, which encodes the G beta 4 subunit, for their potential influence on cancer progression.
|
18815590 |
2008 |
Tumor Cell Invasion
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
As G beta gamma signaling is presumed to be involved in proliferation and invasion processes, we analyzed genetic variations in regulatory regions of GNB4, which encodes the G beta 4 subunit, for their potential influence on cancer progression.
|
18815590 |
2008 |